BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 11289797)

  • 1. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus latency in human ganglia.
    Kennedy PG
    Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian varicella: a model for human varicella-zoster virus infections.
    Gray WL
    Rev Med Virol; 2004; 14(6):363-81. PubMed ID: 15386593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infection of a human CD4-positive T-cell line.
    Zerboni L; Sommer M; Ware CF; Arvin AM
    Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key issues in varicella-zoster virus latency.
    Kennedy PG
    J Neurovirol; 2002 Dec; 8 Suppl 2():80-4. PubMed ID: 12491156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
    J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: The neurobiology of varicella zoster virus infection.
    Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM
    J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract]   [Full Text] [Related]  

  • 17. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
    Hakami MA; Khan FR; Abdulaziz O; Alshaghdali K; Hazazi A; Aleissi AF; Abalkhail A; Alotaibi BS; Alhazmi AYM; Kukreti N; Binshaya AS
    Rev Med Virol; 2024 Jul; 34(4):e2554. PubMed ID: 38862398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
    J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.